Twenty months after the launch of the Make in India campaign, the government has begun assessing the impact of PM Narendra Modi´s flagship programme and is looking to even tweak some of the elements.
FlashNews:
IIFCL Launches Strategic Document to Support Green Infra
REC Reports Record Half-Yearly Profit of ₹74.48 Billion
RAHSTA to submit policy recommendations to NHAI
Roads & Highways Builders book RAHSTA Expo
Are Projects facing a 90 percent barrier?
RAHSTA Forum sets the stage for groundbreaking discussions in roads infra
NBCC sells office/commercial space worth Rs. 14,800 Crore approx
RAHSTA Forum to kick off road and highway expo journey
Infrastructure Experts to Debate Viksit Bharat at Infrastructure Today Conclave in Delhi
Land Pooling Sinks under Flip Flops!
Gods or Demi-Gods cannot prevent a stampede
RAHSTA to showcase cutting-edge road construction tech, says NCC Director
RAHSTA will drive road construction innovation: Sundaresan
Trimble MD champions digital solutions for industry growth at RAHSTA
Vipin Sondhi: Indian infra booms with road construction opportunities
RK Pandey promotes safe road development at RAHSTA launch
RAHSTA to pave the way for innovation in road construction: AK Singh, NHAI
Road construction leaders launch RAHSTA Expo 2024 in Delhi
Road construction industry launches RAHSTA Expo 2024 in Delhi
Home » Pharma
Tag: Pharma
Post
Post
Manufacturing awaits Infrastructure
It is against a challenging backdrop that the ´Make in India´ campaign promises much. To be sure, the country´s manufacturing sector is at a critical point. And it´s been stuck there for sometime now.